Wilson Sonsini Goodrich & Rosati advised Replace Therapeutics on the transaction. Tome Biosciences, Inc., a programmable genomic integration (PGI) company, announced that it has acquired Replace...
Tome Biosciences’ Acquisition of Replace Therapeutics
Riverwood Capital’s $1.8 Billion Closing for Tech Funds
Simpson Thacher & Bartlett represented Riverwood Capital in the deal. Riverwood Capital (“Riverwood”) announced it raised approximately $1.8 billion to invest in high-growth technology businesses globally. Founded in...
Gläubiger übernehmen Mehrheit an Takko Fashion
Freshfields Bruckhaus Deringer hat Silver Point Capital, AlbaCore Capital und Napier Park Global Capital beraten. Arendt & Medernach hat Silver Point Capital beraten. Gleiss Lutz, Ernst...